Efficacy and safety of Apixaban in the treatment of cerebral venous sinus thrombosis: a multi-center study

Efficacy and safety of Apixaban in the treatment of cerebral venous sinus thrombosis: a multi-center study

BackgroundInformation regarding the safety and efficacy of specific direct oral anticoagulants (DOAC) in the treatment of cerebral sinus and venous thrombosis (CSVT) is scarce. Apixaban is one of the most frequently prescribed DOACs. Therefore, we aimed to compare the safety and efficacy of Apixaban...

Full description

Bibliographic Details
Main Authors: Naaem Simaan, Issa Metanis, Asaf Honig, Hen Hallevi, Andrei Filioglo, Rom Mendel, Rani Barnea, Jonathan Naftali, Eitan Auriel, Shorooq Aladdin, David Orion, Najib Dally, Ronen R. Leker, Jeremy Molad
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-05-01
Series:Frontiers in Neurology
Subjects:
Apixaban
cerebral sinus and venous thrombosis (CSVT)
stroke
direct oral anticoagulants (DOAC)
vitamin K antagonists (VKA)
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2024.1404099/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2024.1404099/full

Similar Items